EN
HI
Astrazeneca Pharma India Chart
Astrazeneca Pharma India Share Key Metrics
Volume
1700.00
Market Cap
21468.75 CR
LTQ@LTP
1@8587.50
ATP
8600.61
Var Margin
15.94 %
Circuit Range
6872-10307
Delivery %
42.01 %
Value
1.46 CR
ASM/GSM
No
Market Lot
1
Summary
Astrazeneca Pharma India share price is ₹8587.5 as of 23 May, 2026. The stock Astrazeneca Pharma India intraday movement has stayed between ₹8562.00 and ₹8661.50, while on a 52-week basis,Astrazeneca Pharma India price 52 week high is ₹10691.00 & its 52 week low is ₹7551.50.
In terms of trading activity, Astrazeneca Pharma India has recorded a volume of 1700 shares, The Astrazeneca Pharma India has a market cap of ₹25000000 CR. The stock’s Average Traded Price (ATP) stands at ₹8600.61, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹8587.50.
Astrazeneca Pharma India operates within a circuit range of ₹6872.00 – ₹10307.00, with a Value of ₹1.46 CR. The Delivery Percentage for the day is 42.01%. Additionally, Astrazeneca Pharma India currently falls under the No framework, and trades with a market lot size of 1.
Astrazeneca Pharma India Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
71.49
Sector P/B
3.47
Sec. Div. Yield
0.55
Astrazeneca Pharma India Resistance and Support
Pivot 8624
Resistance
First Resistance
8673.5
Second Resistance
8757.5
Third Resistance
8807
Support
First Support
8540
Second Support
8490.5
Third Support
8406.5
Astrazeneca Pharma India Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results & Dividend |
| 2025-02-11 | Quarterly Results |
Astrazeneca Pharma India News
AstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015
AstraZeneca Pharma India received approval from CDSCO for an additional indication for its drug Calquence® (Acalabrutinib maleate tablets 100 mg). This approval allows the drug to be marketed for previously untreated mantle cell lymphoma, expanding its treatment scope.
May 21 2026 13:05:00
AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
AstraZeneca Pharma shareholders approved the relocation of its registered office from Karnataka to Maharashtra, which also requires an amendment to the Memorandum of Association. This change is subject to various regulatory approvals.
May 12 2026 18:05:00
Read More
About Astrazeneca Pharma India
NSE : 5610
BSE : 506820
ISIN : INE203A01020
Astrazeneca Pharma India Management
| Name | Position |
|---|---|
| Shilpa Divekar Nirula | Chairperson |
| Revathy Ashok | Non Executive Independent Director |
Astrazeneca Pharma India Similar Stocks
Pfizer Ltd.
4670.80
19.50 (0.42%)
Onesource Specialty Pharma Ltd.
1834.50
-27.30 (1.47%)
Neuland Laboratories Ltd.
16693.00
3.00 (0.02%)
Natco Pharma Ltd.
1169.70
-4.60 (0.39%)
Eris Lifesciences Ltd.
1343.80
-42.10 (3.04%)
Granules India Ltd.
751.95
-12.25 (1.60%)
Jubilant Pharmova Ltd.
1006.35
-5.30 (0.52%)
Cohance Lifesciences Ltd.
418.55
-1.35 (0.32%)
Caplin Point Laboratories Ltd.
2028.00
2.10 (0.10%)
Alembic Pharmaceuticals Ltd.
755.70
6.80 (0.91%)
Astrazeneca Pharma India FAQs
The Buying Price of Astrazeneca Pharma India share is 8587.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Astrazeneca Pharma India stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Astrazeneca Pharma India, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Astrazeneca Pharma India shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Astrazeneca Pharma India shares is 0. Useful to assess the stock's value relative to its book value.
To assess Astrazeneca Pharma India’s valuation compare Sector P/E, P/B which are 71.49 & 3.47 with sector averages, along with growth rates and financial metrics.
The Market Cap of Astrazeneca Pharma India is 21468.75 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Astrazeneca Pharma India share price is 10691.00 & 7551.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Astrazeneca Pharma India belongs to the Healthcare sector.
